"Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced intensity conditioning HCT" by Ashley Geerlinks

Selected Works of Ashley Geerlinks

Follow Contact

Article

Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced intensity conditioning HCT

Blood Advances (2023)

Ashley Geerlinks, Western University

Download

Disciplines

Pediatrics

Publication Date

2023

Citation Information

Ashley Geerlinks. "Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced intensity conditioning HCT" Blood Advances (2023)
Available at: http://works.bepress.com/ashley-geerlinks/2/